Castration-resistant Prostate Cancer: Clinical Trials

1 trial for Castration-resistant Prostate Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Active not recruiting 1

Follow Castration-resistant Prostate Cancer: new trials by email Literature Review of Castration-resistant Prostate Cancer trials Research Report on Castration-resistant Prostate Cancer

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer
Bone modifying agent - Breast Cancer, Castration-resistant Prostate Cancer
Phase 4Active not recruitingOttawa Hospital Research Institute2402020-10-092026-07-21

Narrower conditions

Breast Neoplasms (1)

Broader conditions

Breast Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Denosumab (1)  ·  Pamidronate (1)  ·  Zoledronic Acid (1)

Sponsors

Ottawa Hospital Research Institute (1)

Countries

Canada (1)

Top investigators

Terry Ng, MD (1)